ALKBH3 and ovarian carcinoma: In ovarian cancer, ALKBH3 can extend the half-life of CSF-1 mRNA and enhance the expression of CSF-1 by making CSF-1mRNA near the origin of translation 5’UTR region m1A demethylation, thereby improving the invasion ability of ovarian cancer cells (91).